SEC charges two former Ariad executives with insider trading
June 27, 2017 at 13:12 PM EDT
The allegations stem from the Cambridge biotech's discussions with the FDA in 2012 and 2013 regarding cancer drug Iclusig.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|